Acorda Therapeutics Inc. (ACOR)

Business: Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States.

IPO Date: 10-Feb-2006

Founder, CEO, Pres & Director: Dr. Ron Cohen M.D.

Chief Operating Officer: Ms. Lauren M. Sabella

Listing: NASDAQ: ACOR

Country: United States

Headquarters: Ardsley, NY

Website: https://www.acorda.com

Market cap: $10.96 Mln

Revenue (TTM): $122.74 Mln

Earnings (TTM): $-95.02 Mln

Cash: $31.87 Mln

Total Debt: $193.35 Mln

Insider's Holding: 1.33%

Liquidity: Low

52 Week range: $0.28 - 4.99

Shares outstanding: 24,277,800

10 Years Aggregate:

• CFO: $257.02 Mln
• EBITDA: $-357.87 Mln
• Net Profit: $-500.68 Mln